ESOPHAGEAL SQUAMOUS CELL CANCER
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control ENROLLING_BY_INVITATIONThis study tests a new drug called RNDO-564, alone or with another drug (pembrolizumab), in people with advanced solid tumors (like lung, bladder, or breast cancer) that no longer respond to standard treatments. The main goals are to check safety, find the best dose, and see if t…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: Rondo Therapeutics • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New drug duo targets tough-to-treat cancers in early trial
Disease control OngoingThis study tests a new combination of drugs (futibatinib plus a PD-1 antibody) in adults with advanced esophageal or pancreatic cancer that cannot be removed by surgery. The goal is to see if the combo shrinks tumors and is safe. About 53 people will take part, and they must not …
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CANCER
Phase: PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated May 19, 2026 11:59 UTC